Skip to content

Cater With Care Effect Study

Effectiveness of Cater With Care Products in Reaching Recommendations for Protein Intake During and After Hospital Stay and in Improving Functional Status After Hospital Stay in Elderly Patients.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02213393
Acronym
CwC
Enrollment
162
Registered
2014-08-11
Start date
2014-10-31
Completion date
2015-10-31
Last updated
2015-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Undernutrition

Keywords

undernutrition, nutritional status, elderly patients, protein, enriched products, recovery, physical function, quality of life, activities of daily living

Brief summary

The objective is to study the effectiveness of supplementing a standard hospital and 12-week home menu with protein-enriched Cater with Care products in reaching a protein intake of 1,2-1,5 g/kg body weight/day and in improving functional status after hospital stay in elderly patients.

Detailed description

Rationale: About 25% of hospitalized elderly patients are at risk of undernutrition at admission. Many hospitals provide an energy and protein enriched diet, extra snacks, and oral nutritional supplements if needed. Still, a considerable part of these patients are unable to meet protein requirements and are still at risk of undernutrition at hospital discharge. This may impair recovery of illness, partly due to loss of muscle mass and physical performance. To improve protein intake, Cater with Care products have been developed: a selection of foods and drinks that are consumed often by elderly persons, but now enriched with protein up to 10 grams per portion. We hypothesize that these products help to reach protein requirements in elderly patients during and after hospital stay and thereby improve their health outcomes. Objective: To study the effectiveness of supplementing a standard hospital and 12-week home menu with protein-enriched Cater with Care products in reaching a protein intake of 1,2-1,5 g/kg/day and in improving functional status after hospital stay in elderly patients. Study design: Randomised Controlled Trial (RCT) with 2 intervention groups and two phases: a hospital phase including all admitted patients and a home phase with a selection of patients. Study population: Patients of 65 years or over who are admitted to the departments of Geriatrics, Pulmonary Disease, or Internal Medicine of Hospital Gelderse Vallei. Intervention: The control group receives the standard hospital menu for elderly at risk of undernutrition (energy and protein rich) and a variety of foods and drinks to be used as part of their home diet for 12 weeks after hospitalization. Foods and drinks for home use are non-enriched variants of Cater with Care products (e.g. normal fruit juice). The intervention group receives Cater with Care protein-enriched foods and drinks during hospital stay (in addition to the standard hospital menu) and at home as part of their home diet for 12 weeks.

Interventions

DIETARY_SUPPLEMENTProtein enriched products

The intervention group receives CwC protein enriched products. After discharge the intervention group receives CwC products delivered at home for 12 weeks.

DIETARY_SUPPLEMENTUsual menu

The control group receives the usual menu, which is energy and protein rich in this elderly patient group. After discharge the control group receives regular products, no protein enrichment, at home for 12 weeks.

Sponsors

Wageningen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Hospital phase: * admitted to the wards of Geriatric medicine, Pulmonary Medicine, or Internal Medicine in Hospital Gelderse Vallei * aged 65 years or over * being eligible for receiving a standard protein enriched menu based on hospital protocol * Home phase: * included in the hospital phase of the study * consent to continue treatment and study participation after hospital discharge

Exclusion criteria

* Hospital phase: * unwilling to give consent for gathering data from the medical record or meal service system * unable to understand Dutch * food allergies, food intolerances or other dietary restrictions that prevents the patient from receiving the standard protein enriched menu or Cater with Care products based on the judgement of a dietician and/or medical staff * expected length of hospital stay less than 4 days * renal insufficiency (eGFR \< 30 ml/min) * starting with tube feeding or total parenteral nutrition within 2 days of admission * refeeding syndrome score \> 0 based on hospital screening tool for refeeding risk * delirium at admission * receiving palliative care * Home phase: * going to a nursing home, rehabilitation centre or hospice after hospital discharge * cognitive impairment or diagnosed with dementia * legally incapacitated

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline Protein intake and Physical functioning at 6 months6 monthsThis study has 2 primary outcomes: protein intake and physical functioning. These will be assessed at baseline (0), and 2, 6, 12 and 24 weeks after hospital discharge.

Secondary

MeasureTime frameDescription
Change in muscle strength from baseline to 6 months.6 monthsMuscle strength (leg and hand grip) will be assessed at baseline (0), and 2, 6, 12 and 24 weeks after hospital discharge.
Change in nutritional status from baseline to 6 months.6 monthsNutritional status (MNA and dietary intake) will be assessed at baseline (0), and 2, 6, 12 and 24 weeks after hospital discharge.
Change in Quality of Life from baseline to 6 months.6 months.Quality of Life will be assessed with the EuroQoL-5D-5L (at baseline, and 12 and 24 weeks after hospital discharge)
Change in Activities of Daily Living from baseline to 6 months.6 monthsActivities of Daily Living (ADL) will be assessed by using the Barthel index (at baseline, and 2, 6, 12 and 24 weeks after hospital discharge).

Other

MeasureTime frameDescription
Physical Activity6 monthsPhysical Activity will be assessed by using the LAPAQ questionnaire.
Length of hospital stay12 weeksThe length of hospital stay will be recorded to include in an economic evaluation.
Costs of hospital stay12 weeksAfter discharge from the hospital, the costs of hospital stay will be calculated to include in the economic evaluation.
BMI6 monthsBMI is calculated from weight and length measurements at baseline (0), 2, 6, 12, 24 weeks after hospital discharge.

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026